Streetbeat News

Products Services

OCUL

Ocular Therapeutix has accelerated the SOL-1 registrational trial for Wet AMD, with full enrollment expected by the end of 2024 and topline data anticipated in Q4 2025.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:40 am

BMR

Beamr Imaging has announced a collaboration with Bridge Digital, a video technology integrator. This partnership aims to enhance Beamr's video compression technology and expand its market reach.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:39 am

CI

Cigna Healthcare will offer affordable health care plans in 11 states through the Individual Marketplace in 2025, featuring 24/7 virtual care, diabetes assistance, and incentives for healthy behaviors.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:35 am

AAPL

Apple's iPhone 16 has driven record sales for the company in Q3 2024, capturing an 18% market share, just behind Samsung. Despite mixed analyst opinions, the iPhone 16 series is expected to boost Apple's performance into 2025.

Portfolio Pulse from Rounak Jain

October 15, 2024 | 11:35 am

JAZZ

Jazz Pharmaceuticals announced results for its combination therapy of Zepzelca and Atezolizumab in first-line maintenance for small cell lung cancer. The company plans to submit a supplemental New Drug Application in the first half of 2025.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:35 am

ZENA

ZenaTech's subsidiary, ZenaDrone, has initiated a US trial for its IQ Nano Drone. This development marks a significant step in ZenaTech's expansion into the US market, potentially impacting its market presence and stock performance.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:35 am

OCEA

Molecure has entered into an exclusive licensing agreement with Ocean Biomedical for its selective YKL-40 inhibitor program, including the lead molecule OAT-3912, for approximately $32 million. This agreement allows for the continued discovery and development of novel YKL-40 modulators.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:34 am

CYN

Cyngn has expanded its dealer network by partnering with Raymond West, a distributor of intralogistics solutions. Raymond West will sell Cyngn's autonomous DriveMod Tugger, which combines Cyngn's AV technology with Motrec's MT-160.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:28 am

LYRA

Lyra Therapeutics has completed enrollment for its Phase 3 ENLIGHTEN 2 trial of LYR-210, targeting chronic rhinosinusitis. The company is also advancing its third gene therapy program with AMT-162 for SOD1-ALS, aiming for rapid proof-of-concept data.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:21 am

MGTX

MeiraGTx has reported positive data from a clinical bridging study of AAV-GAD for treating Parkinson's Disease, meeting the primary objective of safety and tolerability.

Portfolio Pulse from Benzinga Newsdesk

October 15, 2024 | 11:18 am